NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

87 hedge funds and large institutions have $76.9M invested in Navidea Biopharmaceuticals Inc. in 2013 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

17% less call options, than puts

Call options by funds: $1.04M | Put options by funds: $1.26M

Holders
87
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.04M
Puts
$1.26M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$13.5M
2
$8.15M
3
$7.95M
4
$6.7M
5
$6.42M
6
$5.28M
7
$3.62M
8
$3.48M
9
$3.35M
10
$2.14M
11
$1.64M
12
$1.33M
13
$1.27M
14
$1.03M
15
$965K
16
$865K
17
$746K
18
$718K
19
$536K
20
$492K
21
$448K
22
$396K
23
$324K
24
$295K
25
$289K